Literature DB >> 15003886

The idiopathic hypereosinophilic syndrome and eosinophilic leukemias.

Barbara Bain1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15003886

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  2 in total

1.  Sorafenib is a potent inhibitor of FIP1L1-PDGFRalpha and the imatinib-resistant FIP1L1-PDGFRalpha T674I mutant.

Authors:  Els Lierman; Cedric Folens; Elizabeth H Stover; Nicole Mentens; Helen Van Miegroet; Werner Scheers; Marc Boogaerts; Peter Vandenberghe; Peter Marynen; Jan Cools
Journal:  Blood       Date:  2006-04-27       Impact factor: 22.113

2.  Hypereosinophilic syndrome associated with acute necrotizing myocarditis and cardiomyopathy.

Authors:  M Huntgeburth; M Lindner; J W U Fries; U C Hoppe
Journal:  Z Kardiol       Date:  2005-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.